(Q38066763)

28 August 2017

1 reference

title

The rationale for initiating treatment of hypercholesterolemia in young adulthood (English)

1 reference

28 August 2017

0 references

1 reference

Daniel Steinberg

1

1 reference

28 August 2017

publication date

1 January 2013

1 reference

Current Atherosclerosis Reports

28 August 2017

published in

1 reference

28 August 2017

volume

15

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

296

1 reference

CORONARY DISEASE AMONG UNITED STATES SOLDIERS KILLED IN ACTION IN KOREA

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Environmental and genetic risk factors in early human atherogenesis: lessons from the PDAY study. Pathobiological Determinants of Atherosclerosis in Youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Biomedicine. Lowering LDL--not only how low, but how long?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Evidence mandating earlier and more aggressive treatment of hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Metabolic Studies in an Unusual Case of Asymptomatic Familial Hypobetalipoproteinemia with Hypoalphalipoproteinemia and Fasting Chylomicronemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Statin treatment in children with familial hypercholesterolemia: the younger, the better

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Genomewide association analysis of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Earlier intervention in the management of hypercholesterolemia: what are we waiting for?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Statin treatment does not cause cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Framingham risk score and prediction of lifetime risk for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Can we dramatically reduce the incidence of coronary heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0296-2

Coronary disease among United States soldiers killed in action in Korea; preliminary report

21 January 2018

1 reference

12 December 2020

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

1 reference

12 December 2020

Natural history and risk factors for early human atherogenesis. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

1 reference

12 December 2020

High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound

1 reference

12 December 2020

Starting Earlier to Prevent Heart Disease

1 reference

12 December 2020

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

1 reference

12 December 2020

The distribution and composition of serum lipoproteins in eighteen animals

1 reference

12 December 2020

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

Statins for primary prevention of coronary artery disease

1 reference

12 December 2020

10.1007/S11883-012-0296-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1009973179

0 references

Fatcat ID

release_akvduloecjendpmaw5wgcosp7a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/akvduloecjendpmaw5wgcosp7a

24 November 2022

mapped directly with Wikidata item

1 reference